CMS Issues Request for Information on Medicare Hospice
October 8, 2014 03:18 PM
On October 2, 2014 CMS announced a request for information regarding health plan innovation. Specifically, CMS is requesting information on hospice and Medicare Advantage (MA) and Medicare Advantage – Prescription Drug (MA-PD) plans.
Currently, the Medicare hospice benefit is “carved out” of the MA and MA-PD benefit package. When an eligible MA beneficiary elects the hospice benefit, all Medicare-covered services the beneficiary receives while in hospice care are covered by original Medicare.
Consequently, Medicare beneficiaries are required to forgo curative care to receive access to palliative care services offered by hospices. CMS is researching interest in approaches that would give participating MA and MA-PD plans the option to offer hospice benefits concurrently with curative care to plan enrollees.
Specifically, the CMS RFI asks:
What factors should CMS consider if it were to develop a model that integrates hospice benefits concurrently with curative care in the MA population? In your response, please consider quality and outcomes metrics, beneficiary protections, and any other design factors you think are important.
If CMS were to implement a model that allows plans to integrate hospice benefits concurrently with curative care in the MA populations, and your organization was interested in participating in such a model, how much lead time would you need to prepare the bid in view of the June bid cycle?
In addition to the request for information regarding hospice and MA and MA-PD, CMS also requests information on Medicaid managed care models asking “Would you recommend that CMS implement a Medicaid managed care model test in….hospice?”
Responders are able to provide information via a fillable form from CMS or submitting comments electronically.
NAHC and HAA will be submitting comments. If you would like your comments included in the NAHC and HAA response please submit them to Katie@nahc.org or TMF@nahc.org by October 31, 2014. All comments are due to CMS by November 3, 2014.